Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekAJMC ↗
High-Intensity IV Iron Replacement for Chronic Bleeding in HHT: A Case Series…
The WeekBioPharma Dive ↗
Eli Lilly impressed with its amylin-Zepbound combination data. Elsewhere, Novo demonstrated continued weight l…
The WeekKFF Health News ↗
This page displays an interactive map of the current status of state decisions on the Affordable Care Act's Me…
The WeekKFF Health News ↗
The average Medicare beneficiary will have 28 Medicare Advantage prescription drug (MA_PD) plans available for…
The WeekPharmaVoice ↗
Patients in psychedelic trials often know if they're taking the study drug or a placebo. But trial design chan…
The WeekBriefing
CMS said 2027 Medicare Advantage premiums are projected to fall 16.5%. The immediate read is less about headli…
The WeekSTAT News ↗
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against…
The WeekPharmaceutical Technology ↗
The US FDA has expanded the approved indication for BMS' Camzyos to treat symptomatic oHCM in adults and paedi…
The WeekAJMC ↗
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D…
The WeekBriefing
STAT’s summary said Anthropic joined a clinical AI effort by ARPA-H. The limited disclosure keeps this a signa…
The WeekSTAT News ↗
An investor lawsuit against UnitedHealth Group will move forward after a federal judge declined the company's …
The WeekAJMC ↗
Proposed Medicare Rate Cuts Draw AASM Opposition Ahead of Final Rule…
The WeekPharmaceutical Technology ↗
Data arrives as drugmakers race to bring successors to popular obesity therapies like semaglutide and tirzepat…
The WeekBioPharma Dive ↗
A spokesperson confirmed that a "limited number" of liver-related safety events, including a patient death, we…
The WeekBioPharma Dive ↗
The FDA previously hadn't ever accepted an application of a drug like fenebrutinib in two major forms of MS. B…
The WeekPharmaVoice ↗
Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatm…
The WeekKFF Health News ↗
This brief examines the legal status of Crisis Pregnancy Centers, attempts to regulate them, and future effort…
The WeekPharmaVoice ↗
The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety co…
The WeekBriefing
AJMC flags IRA, 340B, and Medicaid as converging pressures on community oncology. The policy mix points to tou…
The WeekSTAT News ↗
"The surest way to secure our biotech lead is to build up our own capabilities," write Gary Locke and Patrick …
The WeekPharmaceutical Technology ↗
Kyowa Kirin International has signed an exclusive distribution agreement with Knight Therapeutics for Potelige…
The WeekAJMC ↗
Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures…
The WeekKFF Health News ↗
This brief describes the verification process for Medicaid work requirements in Nebraska and examines early da…
The WeekBioPharma Dive ↗
Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatm…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.